MaxCyte (MXCT) Insider Trading & Ownership $3.79 -0.17 (-4.29%) (As of 09/6/2024 08:49 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MaxCyte (NASDAQ:MXCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$489,113.29Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$704,387.93 Get MXCT Insider Trade Alerts Want to know when executives and insiders are buying or selling MaxCyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MXCT Insider Buying and Selling by Quarter Ad Paradigm PressKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. MaxCyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/4/2024Stanley C ErckDirectorSell29,767$3.97$118,174.99 8/26/2024John Joseph JohnstonDirectorSell3,000$4.28$12,840.00 8/1/2024Thomas M RossEVPSell15,476$4.54$70,261.04 7/26/2024John Joseph JohnstonDirectorSell3,000$4.75$14,250.00 7/9/2024Thomas M RossEVPSell13,531$4.03$54,529.93 6/27/2024John Joseph JohnstonDirectorSell10,000$3.99$39,900.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/20/2024Thomas M RossEVPSell33,333$4.09$136,331.97 6/10/2024Maher MasoudCEOBuy70,443$4.90$345,170.70 6/7/2024Maher MasoudCEOBuy29,557$4.87$143,942.59 3/26/2024John Joseph JohnstonDirectorSell5,000$4.41$22,050.00 1/26/2024John Joseph JohnstonDirectorSell5,000$5.12$25,600.00 12/26/2023John Joseph JohnstonDirectorSell5,000$4.53$22,650.00 12/1/2023Douglas DoerflerCEOSell20,200$5.00$101,000.00 11/29/2023Douglas DoerflerCEOSell5,350$5.00$26,750.00 11/27/2023John Joseph JohnstonDirectorSell5,000$4.59$22,950.00 11/14/2023John Joseph JohnstonDirectorSell10,000$3.71$37,100.00 (Data available from 1/1/2013 forward) MXCT Insider Trading Activity - Frequently Asked Questions Who is on MaxCyte's Insider Roster? The list of insiders at MaxCyte includes Casdin Partners Master Fund, L, Douglas Doerfler, John Joseph Johnston, Maher Masoud, Richard Douglas, Stanley C Erck, Thomas M Ross. Learn more on insiders at MXCT. What percentage of MaxCyte stock is owned by insiders? 3.00% of MaxCyte stock is owned by insiders. Learn more on MXCT's insider holdings. Which MaxCyte insiders have been buying company stock? The following insiders have purchased MXCT shares in the last 24 months: Maher Masoud ($489,113.29), and Richard Douglas ($345,600.00). How much insider buying is happening at MaxCyte? Insiders have purchased a total of 180,000 MXCT shares in the last 24 months for a total of $834,713.29 bought. Which MaxCyte insiders have been selling company stock? The following insiders have sold MXCT shares in the last 24 months: Casdin Partners Master Fund, L ($4,525,083.90), Douglas Doerfler ($665,110.62), John Joseph Johnston ($264,769.39), Stanley C Erck ($118,174.99), and Thomas M Ross ($261,122.94). How much insider selling is happening at MaxCyte? Insiders have sold a total of 1,102,889 MaxCyte shares in the last 24 months for a total of $6,317,230.10 sold. More Insider Trading Tools from MarketBeat Related Companies: Arcturus Therapeutics Insider Selling Heron Therapeutics Insider Selling MeiraGTx Insider Selling MacroGenics Insider Selling Harvard Bioscience Insider Selling AnaptysBio Insider Selling LiveRamp Insider Selling Sterling Check Insider Selling NV5 Global Insider Selling E2open Parent Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock3 Small Cap Stocks Insiders Are Actively BuyingTop 2 High-Yield Stocks That Insiders Are BuyingInsider Selling: When It Matters and When It Doesn't This page (NASDAQ:MXCT) was last updated on 9/9/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredForget polls, focus on these 5 tickersWith all the geopolitical tensions in the world… all the inflation… all the expectations of a new round of Fed...StockEarnings | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.